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Abstract
The respiratory system consists of an integrated network of organs and structures that primarily function for gas exchange.
In mammals, oxygen and carbon dioxide are transmitted through a complex respiratory tract, consisting of the nasal
passages, pharynx, larynx, and lung. Exposure to ambient air throughout the lifespan imposes vulnerability of the
respiratory system to environmental challenges that can contribute toward development of disease. The importance of the
respiratory system to human health is supported by statistics from the Centers for Disease Control and Prevention; in 2015,
chronic lower respiratory diseases were the third leading cause of death in the United States. In light of the significant
mortality associated with respiratory conditions that afflict all ages of the human population, this review will focus on basic
and preclinical research conducted in nonhuman primate models of respiratory disease. In comparison with other
laboratory animals, the nonhuman primate lung most closely resembles the human lung in structure, physiology, and
mucosal immune mechanisms. Studies defining the influence of inhaled microbes, pollutants, or allergens on the
nonhuman primate lung have provided insight on disease pathogenesis, with the potential for elucidation of molecular
targets leading to new treatment modalities. Vaccine trials in nonhuman primates have been crucial for confirmation of
safety and protective efficacy against infectious diseases of the lung in a laboratory animal model that recapitulates
pathology observed in humans. In looking to the future, nonhuman primate models of respiratory diseases will continue to
be instrumental for translating biomedical research for improvement of human health.
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Introduction
The mammalian respiratory system consists of a complex
series of passageways (nasal cavity, larynx, trachea, bronchi)
for transportation of air to and from regions of gas exchange
(alveoli). Beyond serving as a conduit for respiration, various re-
gions of the lung mucosa are equipped with structural and
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hematopoietic cell populations that have a protective function
for overall immunity within the individual. Products of the
environment, whether infectious or toxicological in nature,
often elicit a protective response of the respiratory system that
results in short-term morbidity or chronic disease. To under-
stand the biological consequences of inhaled environmental
challenges as well as effectively design strategies to mitigate
pulmonary disease that contributes to morbidity and mortality
in humans, it is critical to conduct basic and translational
research in a laboratory animal model that closely recapitulates
the respiratory tract of humans. Although genetically modified
rodents continue to be the backbone of respiratory diseases
research, nonhuman primate species are essential for under-
standing the progressive pathogenesis of conditions that are
initiated during early life. Moreover, immune and physiologic
parameters in the nonhuman primate closely reflect the com-
plexity of human systems. While the costs for nonhuman pri-
mate research may be prohibitive of large-scale animal
experiments, the potential for translation to human clinical
trials is of high value. The following sections will discuss the
comparative anatomy and physiology of the nonhuman pri-
mate lung relative to what is known in humans, followed by an
overview of major contributions of this laboratory animal
model in our understanding of inhalation toxicology, chronic
airways disease, and infectious disease. It must be acknowl-
edged that the comparative anatomy of the nonhuman primate
lung has been comprehensively summarized in prior publica-
tions (Plopper and Harkema 2005; Plopper and Hyde 2008). An
important goal for this current review is to build on the com-
parative anatomy knowledge base with translational studies
that expand our understanding of airways physiology and
respiratory immunity in a primate species.
Comparative Anatomy and Physiology of the
Nonhuman Primate Lung
Airway Gross and Microscopic Anatomy
For humans as well as all small and large laboratory mammal
species, the respiratory tract divides at the bifurcation of the
trachea into a right and left lung (reviewed in Plopper and
Harkema 2005). In both humans and rhesus macaque monkeys
(Macaca mulatta), the left lung is divided into two distinct lobes.
In the rhesus monkey, the right lung is divided into four lobes,
whereas the human right lung is divided into three lobes. In
comparison, the rodent left lung is not distinguished by indi-
vidual lobes for the left lung, but does have four distinct lobes
for the right lung, similar to that of the nonhuman primate.
The overall lung mass in the rhesus monkey about 8% of body
weight, in comparison with approximately 6% of body weight
in humans and 30% of body weight in mice. A distinguishing
feature of conducting airway anatomy for primate species is
dichotomous, symmetric branching of the upper intralobar
airways, which transitions to the alveolar regions via several gen-
erations of thin-walled, noncartilaginous bronchioles that contain
outpocketings of alveoli (respiratory bronchioles). Respiratory
bronchioles are not observed in rodent species and the branch-
ing pattern is monopodial, which can result in significantly dif-
ferent deposition profiles for inhaled materials. One feature
common to both primate and rodent species is a high rate of
particle deposition in anatomical regions transitioning from air
conduction to gas exchange, whether respiratory bronchioles
for primates or centriacinar regions for rodents. However, the
cell populations located at that transition from conducting
airway to gas exchange consist of a mixture of ciliated, club,
and alveolar epithelial cells in primates vs a distinct separa-
tion of bronchiolar cells from alveolar epithelial cells in the
rodent. It is unknown if such differences in epithelial cell
complexity contribute to species distinct biological responses
to environmental challenges, but manifestation of small air-
ways diseases such as respiratory bronchiolitis in response to
infection and bronchiolitis obliterans following transplanta-
tion is not uncommon in primate species (reviewed in Burgel
et al. 2013).
On a cellular level, the conducting airway tree of the lung
displays the most species-dependent differences when com-
paring a range of laboratory animal models. From the trachea
through midlevel intralobar airways, the overlying epithelia are
a mixture of ciliated, mucous, and basal cells, along with exten-
sive submucosal glands. The mucosa of conducting airways in
primate species is substantial from the most proximal (trachea)
to distal intralobar regions, containing both cartilage and
extensive smooth muscle. In comparison, the epithelial lining
of the rodent conducting airway tree is predominantly popu-
lated with club cells and ciliated cells and a minimal amount of
lamina propria containing a small number of smooth muscle fi-
bers. The individual cellular constituents that contribute to the
structure of the lung play an important role in many different
acute and chronic respiratory diseases, emphasizing the need
to conduct both basic and translational studies in nonhuman
primates to define mechanisms that promote pathology in hu-
mans. For example, comparison of the airway transcriptome
from the rhesus macaque model and mouse model of house
dust mite-induced asthma shows significantly greater overlap
of gene profiles from monkeys with lung biopsies obtained
from human asthma patients (Abbas et al. 2011).
Airways Physiology
Identifying the mechanical factors within the pulmonary sys-
tem that contribute to ventilatory dysfunction is critical for
understanding and ultimately treating the underlying cause of
chronic airways disease. Moreover, mechanical changes of the
lung in response to perturbations are indicative and diagnostic
for disease status. The size of nonhuman primates commonly
used in biomedical research permits characterization of pulmo-
nary disease processes utilizing techniques common to the
study of human pulmonary disease. Pulmonary function test-
ing has been utilized in nonhuman primate research over the
course of several decades. Initially, studies that measured lung
volumes, capacities, and pulmonary mechanical variables in
nonhuman primates were relatively descriptive in nature but
important for providing a basis for expected values. The rhesus
monkey chest wall is relatively stiff in comparison to small
domestic animals but similar to the human chest wall. This
feature of primate anatomy physiologically gives rise to a
relaxed lung volume known as functional residual capacity,
which comprises a large percentage of the total lung capacity
(Koike et al. 1998; Pare et al. 1978). Dynamic flow parameters,
similar to forced expiratory volume commonly used in human
patients, have also been measured in nonhuman primates and
found to be similar to dogs but larger than that in humans
when normalized to lung size (Kosch et al. 1979).
Common methods of mechanical characterization rely on a
simple model of the pulmonary system giving a pulmonary
resistance and dynamic compliance. A more complex method
that holds promise for extensively characterizing pulmonary
mechanical function with minimal invasiveness is forced
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oscillometry, which is gaining popularity in human patients,
especially those that cannot perform maneuvers comprising
common pulmonary function tests. Forced oscillometry is a
technique that has been under development for many years,
and monkeys have been included as a part of the evaluation
process (DuBois et al. 1956; Wegner et al. 1984). Using a model
system that allows separation of compliance, airway resis-
tance, and tissue resistance, cynomolgus macaque monkeys
(Macaca fasicularis) were found to respond to bronchoactive
agents primarily with changes in airway resistance indicating a
large airway contribution and the frequency dependence of the
response suggesting heterogeneous constriction (Black et al.
2001; Madwed and Jackson 1997). Other studies in monkeys
suggest that peripheral airways contribute about one-third of
lung resistance in response to bronchoactive agents (Pare et al.
1976). Given the availability of techniques enabling identifica-
tion of peripheral airway dysfunction and heterogeneity of ven-
tilation in addition to more standard parameters, and the
fidelity of nonhuman primate lung development and anatomy
to that of human, this laboratory animal model is particularly
relevant to the study of pulmonary disease processes in hu-
mans, especially where small airways play a significant role
(Shaw et al. 2002).
Role of Nonhuman Primates in Inhalation
Toxicology
Ozone
Ozone is a major constituent of photochemical air pollution.
Acute and chronic inhalation studies in nonhuman primates
have played a critical role in defining ozone-induced injury and
inflammatory and repair responses. More recent nonhuman
primate studies have focused on the effects of early-life ozone
exposure on lung development.
Numerous studies have demonstrated ozone-induced le-
sions or inflammation in the conducting airways of rhesus
monkeys and bonnet macaque monkeys (Macaca radiata)
exposed to ozone concentrations of 0.15 to 3.0 ppm for periods
of 2 hours to 7 days (Castleman et al. 1973, 1975, 1977, 1980;
Dungworth et al. 1975; Mellick et al. 1977). A gradient of dam-
age, with the large bronchi having the greatest damage and the
distal bronchioles having the least, has been observed in non-
human primates exposed to high ambient concentrations of
ozone (0.40 and 0.64 ppm) for 8 hours/day for 7 days. Castleman
et al. exposed bonnet monkeys to 0.16 and 0.30 ppm ozone
8 hours/day for 7 days and observed altered cilia and an increase
in nonciliated cells (Castleman et al. 1980). Again, the most
severe damage, involving the largest number of ciliated cells,
was located in the trachea and proximal bronchi, while less
extensive changes were present in more distal bronchi and
respiratory bronchioles. A consistent observation in subacute
exposure studies using nonhuman primates is that surface al-
terations viewed by scanning electron microscopy consist of
randomly scattered patches and longitudinal tracts.
As the number of days of ozone exposure extends beyond
7 days, the lesions in trachea and proximal bronchi recover,
with the epithelium of the large conducting airways becoming
relatively insensitive to continued exposure (Wilson et al.
1984). In contrast, monkeys exposed to 0.15 ppm ozone for 6 or
90 days, 8 hours per day, had significant nasal epithelial lesions
of ciliated cell necrosis, attenuated cilia, secretory cell hyper-
plasia and bronchiolitis consisting of hyperplasia, hypertrophy
of nonciliated bronchiolar epithelial cells, thickening of the
interstitium, and intraluminal accumulations of macrophages
(Harkema et al. 1987, 1993). The development of chronic bron-
chiolitis with prolonged (1–18 months) exposure to high ambi-
ent concentrations of ozone has been demonstrated in multiple
nonhuman primate studies (Eustis et al. 1981; Fujinaka et al.
1985; Harkema et al. 1993; Tyler et al. 1988). Tyler et al. exposed
young nonhuman primates to 0.25 ppm continuously and epi-
sodically every other month for 18 months and observed that
despite delivering one-half of the ozone dose, the episodic
exposure produced larger biochemical and physiological altera-
tions and equivalent morphometric changes (Tyler et al. 1988).
To examine the effect of early-life ozone exposure on lung
development, 1-month old infant rhesus macaques were
exposed to 11 episodes of 5 days (8 hours/day) at 0.50 ppm fol-
lowed by 9 days of filtered air (Schelegle et al. 2003). Compared
with control infants, ozone-exposed animals had reduced epi-
thelial innervation, four fewer nonalveolarized airway genera-
tions, hyperplastic bronchiolar epithelium, altered smooth
muscle bundle orientation in terminal and respiratory bronch-
ioles, and increased alveolar numbers (Avdalovic et al. 2012;
Fanucchi et al. 2006; Larson et al. 2004). These changes were
associated with altered serotonin, substance P, and fibroblast
growth factor signaling in conducting airways (Evans et al.
2003; Moore et al. 2012; Murphy et al. 2012, 2013). The cessation
of exposure for 6 months resulted the normalization of fibro-
blast growth factor signaling and epithelial hyperinnervation,
while airway serotonin signaling remained altered for as long
as 2.5 following the end of exposure (Evans et al. 2004; Kajekar
et al. 2007; Moore et al. 2014). In total, these studies of early-life
episodic ozone exposure provide evidence for prolonged struc-
tural and functional airway changes that could increase the
risk for chronic lung disease as the animal ages.
Tobacco Smoke
Exposure to tobacco smoke is a major contributor to cardiopul-
monary disease. Irritation and chronic inflammation of the air-
ways and alveoli lead to a myriad of conditions including
bronchitis, chronic obstructive pulmonary disease (COPD), and
emphysema, as well as multiple forms of benign and malignant
lung cancer. According to the World Health Organization, COPD
is the fourth leading cause of death in the world today. Exposure
to tobacco smoke can be either active or passive and represents
the more preventable type of lung disease known through smok-
ing cessation and regulation.
Nonhuman primates have been key in advancing our under-
standing of the mechanisms of smoke-induced lung disease
due to early-life exposure to second-hand smoke, also known
as environmental tobacco smoke. Early-life exposure to
second-hand smoke can have significant consequences on the
normal development of a wide variety of organ systems but in
particular the respiratory system. Exposure to low levels of
environmental tobacco smoke (1mg/m3) during pregnancy
(beginning at gestation day 50) through the first 2 months of
postnatal life downregulates NF-kappaB-dependent antiapop-
totic genes to induce the activation of caspase cleavage of cel-
lular death substrates (poly(ADP)-ribose polymerase and
caspase-activated DNase), thus increasing the rate of apoptosis
in the neonatal lung parenchyma. These events directly com-
promise normal cell proliferation with the potential to impair
normal lung growth and function in early life (Zhong et al.
2006).
Exposure to environmental tobacco smoke during early life
in the nonhuman primate also enhances local T(H)2 immunity
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by impairing normal pulmonary T(H)1 immune maturation.
This effect is greater in animals beginning environmental tobacco
smoke (ETS) exposure in utero in contrast to infants exposed only
postnatally. Neonatal monkeys exposed in utero and during the
first 6 months of postnatal life demonstrate significant downregu-
lation in mRNA for IFN-gamma, IL-2, IFN-gamma-inducible pro-
tein 10, monokine induced by IFN-gamma, IFN-gamma-inducible
T-cell chemoattractant, CXC chemokine receptor 3, IL-12 bioactive
p70 subunit, and T-bet. In contrast, infant monkeys exposed only
during postnatal life (6–13 months of age) to ETS show a sig-
nificant downregulation only in IFN-gamma, CXC chemokine
receptor 3, and IL-12p70, while levels of mRNA for thymus and
activation-regulated chemokine are increased and IL-10 protein
is reduced (Wang et al. 2008).
Perinatal ETS exposure in monkeys can induce both systemic
and local responses, with significant elevations in plasma levels
of C5a and brain-derived neurotrophic factor, as well as signifi-
cant increases in the expression of proinflammatory cytokine
TNF-alpha and T(H)2 cytokine IL-5, chemokine monocyte che-
moattractant protein 1 in the lungs, along with a significant
increase in the presence of substance P-positive nerves along the
bronchial airways to innervate the epithelial lining of the lungs.
Perinatal ETS exposure also significantly increases the number of
mast cells, eosinophils, monocytes, and lymphocytes in the
lungs of infant monkeys (Yu et al. 2008).
Perinatal exposure to ETS can also induce acute systemic
inflammatory responses in the nonhuman primate to signifi-
cantly alter a variety of immune effectors. Fetal and postnatal
exposure to ETS has been found to alter the normal maturation
of mRNA levels of IFN-gamma, IL-2, and IL-10, as well as the
ratio of CD4 to CD8 lymphocytes, compared with filtered-air
control levels. Blood lymphocyte subset distribution have also
been found to be significantly different, based on the timing of
the onset of exposure to ETS in early life. Even short-term expo-
sure to ETS (2 weeks) in postnatal infant monkeys has been
found to significantly increase the levels of peripheral blood
neutrophils and IL-6 mRNA. These findings suggest normal
immune system development can be significantly compro-
mised by in utero and postnatal exposure to ETS to contribute
to ETS-related childhood diseases (Wang et al. 2007).
Other Inhaled Toxicants
Ozone and tobacco smoke are the most well-studied environ-
mental exposures in nonhuman primate models, likely due to
the strong association of these common air pollutants with
chronic respiratory diseases in humans such as asthma and
COPD. There are limited data available on other inhalation toxi-
cology studies in nonhuman primates. For occupational expo-
sures, chlorine gas and formaldehyde gas have been evaluated
in chronic models in the rhesus macaque, eliciting significantly
different pathology compared with rat models (Klonne et al.
1987; Monticello et al. 1989). The carcinogenicity of long-term
diesel and coal dust exposure was examined in the cynomolgus
monkey; in comparison with the rat, the monkeys showed
minimal evidence of cellular abnormalities (Lewis et al. 1986).
Similar findings were observed in an 11-year follow-up study in
cynomolgus monkeys exposed to asbestos (Stettler et al. 2008).
Despite the pervasiveness of particulate matter (PM2.5 and
PM10) in the environment, there are no known reports of
experimental exposures for this airborne product of combus-
tion in nonhuman primate models. Recently, a cohort of
outdoor-housed adolescent rhesus macaque monkeys exposed
to ambient wildfire smoke (a high source or PM2.5 and PM10)
were evaluated for lung function and immune profiles; animals
exposed at infancy displayed reduced lung volumes and dysregu-
lation of innate immunity, suggesting long-term health impacts
from inhaled particulate matter during early life (Black et al.
2017).
Future Studies
Electronic cigarette use tripled among middle and high
school-age children from 2013 to 2014 (Arrazola et al. 2015).
Adolescents perceive electronic cigarettes to be safer than
traditional cigarettes, resulting in use that is expanded to in-
dividuals who may not use traditional cigarettes (Barrington-
Trimis et al. 2015). Cigarette smoking is overrepresented in
adolescents with psychiatric disorders, but e-cigarette use ex-
tends to an emotionally healthier subset expanding use beyond
those that would use traditional cigarettes (Leventhal et al.
2016; Upadhyaya et al. 2002). Epidemiological estimates indi-
cate electronic cigarette vapor (ECV) carries a risk for asthma in
young people, whereas it may be too early to estimate risk for
COPD. ECV use for 5 minutes in healthy smokers elicits pulmo-
nary function deficits similar to smoking (Cho and Paik 2016;
Vardavas et al. 2012). While perceived as safe alternatives to
traditional cigarettes, current evidence indicates e-cigarettes
will contribute to lung disease. A nonhuman primate model
would be well-positioned to directly assess the acute and
chronic effects of inhalation exposures in the adolescent popu-
lation. Complex behavioral patterns exhibited by monkeys can
also be associated with pulmonary dysfunction and may couple
with exposures such as ECV to exacerbate pulmonary disease
processes, pointing to a monkey model for optimal discovery of
these processes.
Nonhuman Primate Models of Airways
Inflammation
Asthma
With the advent of pulmonary function testing techniques in
nonhuman primates, investigators began characterizing cyno-
molgus monkeys that were naturally infected with the nema-
tode Ascaris suum and showed allergic reactions to the A. suum
antigen (Patterson and Talbot 1969). The model proved to be a
good representation of human atopic asthma and became
widely used by the pharmaceutical industry, which helped
characterize the allergic airway disease (Gundel et al. 1992;
Krell et al. 1986; Osborn et al. 1992; Turner et al. 1996; Young
et al. 1999). The acute allergic airway response in monkeys was
found to be primarily mediated by histamine and cysteinyl leu-
kotrienes (Osborn et al. 1992). The relative potency of cysteinyl
leukotrienes (cys-LT) compared to histamine was variable in
some studies where there may be some regional and species-
specific effects, but inhalation of cys-LT by monkeys does
mimic an asthmatic phenotype (Johnson et al. 1988; Krell et al.
1986; Seehase et al. 2011). The reaction to cys-LT in monkeys
appears to be mediated through a cholinergic reflex in the air-
ways, whereas the parenchymal response showed less
response to cholinergic inhibition (atropine) (Johnson et al.
1988). The monkey model also revealed responders displaying
a late-phase response similar to asthmatics. The late-phase air-
way obstruction was tied to neutrophil influx that is primed by
the presence of eosinophils in the airway and inhibited by
blocking endothelial leukocyte adhesion molecule 1 (Gundel
et al. 1991, 1992).
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The “natural” model of A. suum asthma has given way to
models utilizing active sensitization with a number of different
allergens, such as the common human allergen, house dust mite.
In 2001, the first nonhuman primate model of experimentally
induced asthma using house dust mite (Dermatophagoides farine)
in rhesus monkeys was reported, which was subsequently repli-
cated by other investigators using the cynomolgus monkey
(Schelegle et al. 2001; Van Scott et al. 2004). In the rhesus monkey,
a period of chronic aerosol challenge with house dust mite
resulted in multiple parameters of clinical asthma in hu-
mans, including eosinophilic inflammation in the lung, re-
modeling of conducting airways, and enhanced physiologic
reactivity to a nonspecific stimuli (methacholine) (Schelegle
et al. 2001). This rhesus model of house dust mite-induced
atopic asthma has been utilized in preclinical trials for asthma
therapeutics (Fanucchi et al. 2004; Seshasayee et al. 2007). An
infant rhesus monkey model of childhood asthma that com-
bines the adjuvant properties of ozone with house dust mite
exposure has also been reported; inhaled corticosteroid treat-
ment of infant monkeys that display an asthma phenotype re-
sulted in attenuation of some symptoms but also altered normal
lung growth (Plopper et al. 2012; Schelegle et al. 2003).
COPD
COPD is associated with cigarette smoking, and a few studies
have attempted to model COPD through exposure of monkeys
to tobacco smoke. An early study trained baboons to smoke
and assessed them after 6 pack years of smoking (a common
metric in COPD studies indicating the product of the average
packs per day smoked and years smoking). Interestingly, the
bronchial reactivity was blunted, and residual lung volume was
preserved upon exposure to the cholinergic agonist methacho-
line in the smoking monkeys (Roehrs et al. 1981). Inhalation of
nicotine was found to mediate the blunted methacholine
response while not affecting baseline lung function, whereas
the response to histamine was unaffected (Wallis et al. 1982).
A more recent examination of heavy smoking, approximating 4
packs/day, in cynomolgus monkeys over the course of 4 and
12 weeks provided some insight into the pathological processes
in the monkey model. After 12 weeks, pulmonary function
changes showed minimal differences from sham exposure
(a trend toward reduced FEV), while pathological changes were
more pronounced. Inflammation, mucus metaplasia, glandular
hypertrophy/hyperplasia, and peribronchial fibrosis was evi-
dent in addition to a “pre-emphysemetous” profile indicated by
elevated matrix metalloprotein-9, apoptosis of alveolar septal
cells, and elevated oxidative stress in lung tissue (Polverino
et al. 2015). Using this approach, it was recently reported that a
combination of cigarette smoke and influenza infection in-
creases connective tissue growth factor, which could accelerate
epithelial cell senescence (Jang et al. 2017).
Future Studies
In line with a continuing interest in personalized medicine by
the biomedical research community, there has been a major
push to phenotype human asthma and COPD subjects using
molecular markers based on multiple parameters of clinical
severity. One category of the human patient population that
has proven to be experimentally challenging to replicate in ani-
mal models is the nonatopic or “intrinsic” asthmatic. To date,
there is very little known regarding the underlying mechanisms
that elicit nonatopic asthma, beyond elevated body mass index,
and increased serum IL-6 (Fahy 2015; Peters et al. 2016). In a ret-
rospective study, Capitanio and colleagues reported that a
behaviorally inhibited temperament in rhesus monkeys may be
predictive of intrinsic airways hyperresponsiveness to nonspe-
cific challenge; this finding was subsequently replicated in a
prospective study (Capitanio et al. 2011; Chun et al. 2013). The
underlying pulmonary function deficit associated with the air-
way hyperresponsiveness has not been determined in this nat-
ural model of nonatopic asthma (Royer et al. 2016), but studies
to investigate the immune and genetic basis of this phenotype
should be conducted in the future.
Nonhuman Primate Models of Respiratory
Infection
Nonhuman primates have long served as laboratory animal
models for infectious diseases in humans where the lung is the
primary site of infection and manifestation of illness. In com-
parison with other laboratory animals such as rodent or canine
species, the immune system of the nonhuman primate shows
significant homology with that of the human, which is a critical
characteristic for understanding host-pathogen responses that
lead to identification of therapeutic targets (Messaoudi et al.
2011). Because of similarities in immune mechanisms, nonhu-
man primate models of respiratory infection provide a critical
biomedical resource for accelerating preliminary safety and
efficacy testing of vaccines as well as other pharmaceutical in-
terventions that cannot be ethically evaluated in human sub-
jects prior to clinical trials. On a global scale, pathogens that
target the respiratory system are of particular concern to
human health due to the possibility of airborne transmission,
leading to rapid dissemination of infection via international
travel. The complexity of mechanisms used by certain patho-
gens of the respiratory tract to evade the immune system of
the host has contributed to slow but incremental success in
identifying cellular pathways that may be targeted for drug and
vaccine development. More recent experimental studies in
nonhuman primate models have focused on respiratory viruses
that have evolved from domesticated or wild animal hosts,
along with continued efforts to prevent the establishment of
respiratory infectious disease in the human population using
novel vaccination methods. Fungal and bacterial respiratory in-
fections have also been investigated in nonhuman primate
models, primarily in the context of secondary opportunistic
pathogens in the immunocompromised host. Here, we will
highlight nonhuman primate infection models of the most
common viruses and microbes that target the respiratory tract,
with an emphasis on clinical treatment and prevention strate-
gies that may be translated into the human population.
Tuberculosis (Mycobacterium tuberculosis)
It is estimated by the World Health Organization that more
than 1 million people die each year from tuberculosis (TB), with
more than 8 million individuals becoming newly infected each
year (reviewed in Zumla et al. 2013). Despite the known exis-
tence of this disease since the 1700s, it remains as one of the
top 10 causes of death worldwide, making the search for an
effective vaccine and drugs that do not elicit resistance of the
mycobacterium a priority. One of the oldest experimental non-
human primate models of human respiratory pathogen infec-
tion was developed to address the imperfections of murine
models of Mycobacterium tuberculosis, the causative agent for
TB in humans. A major first step in the establishment of
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nonhuman primate models of TB was reported by Walsh et al.,
in which the cynomolgus monkey was used to demonstrate the
feasibility of infection by intratracheal administration of either
high or low doses of M. tuberculosis; while high doses of the
M. tuberculosis elicited fulminant conditions, low doses resulted
in chronic symptoms that were similar to what has been
described for human patients (Walsh et al. 1996). The cynomol-
gus model was subsequently refined by Capuano et al. using
bronchoscopy for low-dose instillation M. tuberculosis followed
by long-term immune and clinical monitoring of animals, re-
sulting in a cohort that displayed the spectrum of pathological
conditions observed in human populations (Capuano et al.
2003). In the early 1920s, the bacillus Calmette-Guerin (BCG)
vaccine to prevent TB was developed using a weakened strain
of the bovine Mycobacterium bovis; while currently still in use in
many countries, the efficacy of BCG to prevent the develop-
ment of TB is highly variable (Colditz et al. 1994). Findings from
human epidemiology have been borne out by experimental
nonhuman primate studies in a rhesus macaque monkey
model of experimental TB, which clearly supported the obser-
vation of limited efficacy for BCG vaccine (Langermans et al.
2001). Numerous attempts using innovative vaccination ap-
proaches have failed; however, a recent mucosal aerosolization
study of a M. tuberculosis strain engineered with a mutant SigH
region effectively protected rhesus macaques from lethal TB
challenge, suggesting that human clinical trials are imminent
(Kaushal et al. 2015). In addition to serving as a critical labora-
tory animal model for human TB, the nonhuman primate has
been critical for the development of blood diagnostics for detec-
tion of interferon production in response to M. tuberculosis, a
step that has virtually eliminated the need for the less sensitive
and specific tuberculin skin test (Garcia et al. 2004).
Measles (Measles Virus)
Measles is a disease resulting from infection with the measles
virus, which is classified as an RNA virus within the genus
Morbillivirus and Paramyxoviridae family. The measles virus is
highly contagious and readily spread by airborne transmission
following infection within the respiratory tract. Infection with
the measles virus can result in significant morbidity and immu-
nosuppression, leading to enhanced susceptibility to mortality
from childhood infectious disease (Mina et al. 2015). Despite
the availability of effective vaccines since the early 1960s,
resource-poor countries and the recent spate of “antivaccine”
proponents has contributed to a dramatic increase in outbreaks
both globally and within the United States, necessitating inves-
tigation of more robust vaccine strategies to enhance gaps in
immunity (Durrheim 2016; Gastanaduy et al. 2016; Mulholland
et al. 2012). The nonhuman primate is highly susceptible to
infection with the measles virus, and experimental inoculation
can result in acute clinical signs that are comparable to that
observed in humans (Kobune et al. 1996). Surprisingly, little is
known about the cellular and molecular mechanisms by which
the measles virus elicits pathology. Because the respiratory
tract has long been known as the primary source of viral parti-
cles, it had been assumed that epithelial cells were the primary
target, despite the lack of expression for CD150, the known
high affinity receptor for viral entry (Erlenhoefer et al. 2001). In
an elegant study in cynomolgus macaques using a recombinant
green fluorescent protein, labelled measles virus clearly dem-
onstrated that alveolar macrophages and dendritic cells were
the initial sites of viral replication, followed by spread to lym-
phoid aggregates in the oral cavity (Lemon et al. 2011; Ludlow
et al. 2013). More recently, the preferential targeting of antigen-
presenting cells by the measles virus was further supported by
i.m. inoculation of live-attenuated virus in cynomolgus maca-
ques (Rennick et al. 2015). Innovative approaches to achieve
high coverage of vaccination has also been developed in the
nonhuman primate model of measles, including the use of a
microneedle patch that does not require injections (Edens et al.
2015).
Influenza (Influenza Virus)
Influenza is a respiratory disease caused by infection with
either Influenza A or B virus strains, which are RNA viruses of
the orthomyxovirus family. In contrast with seasonal influenza,
infection with pandemic influenza A virus strains is a signifi-
cant concern for human health due to limited immunity on a
global scale, resulting in complications that require hospitaliza-
tion and mortality in at-risk populations. Experimental animal
models of viral infection using the nonhuman primate have
played an essential role in understanding the pathogenesis of
the pandemic influenza A strain H1N1 as well as other highly
pathogenic strains such as avian H5N1 (Davis et al. 2015). From
a mechanistic perspective, the nonhuman primate has been
particularly important for defining immunomodulatory path-
ways that dictate health outcomes in vulnerable populations
with weakened immunity toward vaccine preparations, such as
very young children and geriatric individuals (Asquith et al.
2012; Clay et al. 2014b; Holbrook et al. 2015). Not surprisingly,
both infant rhesus macaques and African green monkeys are
more susceptible to the H1N1 virus, revealing delayed type 1
interferon synthesis and impaired mucosal immunoglobulin
responses following infection. Seasonal influenza vaccines are
not recommended for children under the age of 6 months,
which is a target population that is most vulnerable to hospital-
ization and mortality due to infection. As such, a major empha-
sis for nonhuman primate models of influenza infection is the
investigation of vaccine adjuvants to enhance immunogenicity
in vulnerable populations. To date, inclusion of adjuvants such
as flagellin appears to have modest efficacy in pediatric H1N1
infection models, resulting in enhanced parameters of humeral
immunity (Holbrook et al. 2016a, 2016b). However, cationic
lipid/DNA complexes have been shown to dramatically reduce
viral replication following vaccination with a trivalent inacti-
vated influenza vaccine in geriatric animals challenged with
H1N1 (Carroll et al. 2014).
Viral Bronchiolitis (Respiratory Syncytial Virus)
Infection with respiratory syncytial virus, an RNA virus of the
paramyxoviridate family, is one of the most common respira-
tory infections during early life, with an estimated 20% of chil-
dren infected (reviewed in Meissner 2016). All populations,
from infancy to geriatric, are vulnerable to infection with respi-
ratory syncytial virus, but infants are particularly susceptible to
the development of viral bronchiolitis, often requiring hospital-
ization. Moreover, childhood infection with respiratory syncy-
tial virus is frequently a predictor for development of asthma
later in life (Jackson et al. 2016). Several nonhuman primate
species have been utilized as models of respiratory syncytial
virus infection, including the rhesus macaque, Bonnet monkey
(Macaca radiata), and baboon (De Swart et al. 2002; McArthur-
Vaughan and Gershwin 2002; Papin et al. 2013; Simoes et al.
1999). Vaccine trials for respiratory syncytial virus have pro-
ceeded with caution following several deaths resulting from an
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early trial using a formalin inactivated virus; subsequent test-
ing in nonhuman primates showed that viral challenge elicited
Th2-derived hypersensitivity reactions (De Swart et al. 2002).
To date, there is no safe and effective vaccine for respiratory
syncytial virus; high-risk infants may receive prophylaxis in
the form of a humanized monoclonal antibody targeted against
the viral surface protein.
SARS/MERS (SARS CoV/MERS CoV)
Both severe acute respiratory syndrome (SARS) and Middle East
Respiratory syndrome (MERS) are pulmonary diseases caused
by infection with members of the Coronoviridae family of
single-stranded RNA viruses. Outbreaks of either SARS or MERS
are relatively isolated but result in severe disease and mortality
in susceptible populations. In the first reported outbreak of
SARS in 2003, confirmation of SARS coronavirus as the etiologic
agent for disease was determined by infection of rhesus
macaque monkeys, resulting in symptoms that were compara-
ble to human infection(Rowe et al. 2004). Other studies in
African green monkeys have established that immune deficien-
cies associated with the aging process result in enhanced mor-
bidity following infection with the SARS coronavirus (Clay et al.
2014a). The first known report of MERS took place in 2012, with
additional cases emerging within the same Middle Eastern
region (Arabi et al. 2017). The MERS coronavirus can infect both
the rhesus macaque and common marmoset (Callithrix jacchus),
resulting in clinical symptoms; the marmoset has been re-
ported to develop lethal pneumonia following infection
(Falzarano et al. 2014; Yao et al. 2014).
Fungal and Bacterial Pneumonia (Pneumocystis jirovecii,
Streptococcus pneumoniae, Klebsiella pneumoniae)
The fungus Pneumocystis jirovecii is abundant within the environ-
ment but can be highly pathogenic in immunocompromised hu-
mans, resulting in life-threatening pneumonia. Pneumocystis
pneumonia is frequently associated with human immunodefi-
ciency virus infection; however, individuals undergoing chemo-
therapy and susceptible populations (infant, geriatric) are also
vulnerable to infection (reviewed in Eddens and Kolls 2015).
Confirmation of the role of immune compromise in the patho-
genesis of Pneumocystis pneumonia was experimentally deter-
mined in the macaque model of human immunodeficiency virus
infection using the simian immunodeficiency virus (SIV) (Board
et al. 2003). It was subsequently shown that humeral immunity
to the P. jirovecii protease kexin (KEX1) protein is strongly linked
with health outcomes in the SIV-infected monkey (with corollar-
ies in human patients) (Kling et al. 2010). Vaccination with
recombinant KEX1 peptide resulted in protective humeral immu-
nity against P. jirovecii infection, even in immunosuppressed SIV-
infected monkeys (Kling and Norris 2016).
Similar to fungal pneumonia, susceptible populations are
also more at risk for development of bacterial pneumonia; it is
estimated that Streptococcus pneumoniae contributes to approxi-
mately 11% of deaths in children worldwide (O’Brien et al.
2009). In the late 1970s, models of S. pneumoniae and Klebsiella
pneumoniae were initially described in squirrel monkeys (Saimiri
sciureus), which, in contrast with rodent models, elicited a lobar
pneumonia comparable to that of humans (Berendt et al. 1978,
1975). A rhesus macaque model of S. pneumoniae infection was
subsequently developed and successfully used for evaluation of
a novel protein-based pneumococcal vaccine (Denoel et al.
2011; Philipp et al. 2006). More recently, a severe pneumonia
model has been described in the adult baboon (Papio cynocepha-
lus), primarily for the purpose of identifying new biomarkers of
early stage infection, with the goal of rapid diagnosis and treat-
ment (Kraft et al. 2014; Reyes et al. 2016).
Whooping Cough (Bordatella pertussis)
Whooping cough is an acute respiratory illness of childhood
that is the result of infection with Bordatella pertussis, a highly
contagious gram-negative bacterium that blocks normal muco-
ciliary clearance in the lung by production of a cytotoxin.
Vaccination for B. pertussis has been available since the 1940s,
and an acellular form in conjunction with diphtheria and teta-
nus has been incorporated as a part of routine childhood
immunization schedules for decades (reviewed in Kilgore
et al. 2016). The incidence of whooping cough has steadily
increased over the years, with epidemiologic reports implicat-
ing waning immunity in adolescence contributing to outbreaks
in the United States (Klein et al. 2012). To better understand the
immune basis for declining immunity in juveniles, multiple
species of nonhuman primates have been evaluated as animal
models of B. pertussis. The Taiwanese macaque (Macaca cyclopis)
may become infected with B. pertussis and develop clinical
symptoms; however, availability of this species for research is
limited as it is now considered endangered (Huang et al. 1962).
In contrast with the Taiwanese macaque, approximately 25% of
rhesus macaque monkeys infected with B. pertussis display clin-
ical symptoms that are consistent with human disease (Warfel
et al. 2012). Baboons appear to be a much more reliable nonhu-
man primate infection model for B. pertussis and have recently
yielded important immunological insights on the mechanisms
of diminished vaccine potency in the human population.
Infection of baboons with B. pertussis or vaccination with whole
pertussis results in long-lasting Th17 and Th1 immunity; how-
ever, the currently used acellular pertussis vaccine elicited a
mixed Th1/Th2 immunity, suggesting that T cell effector mech-
anisms may be critical for robust disease protection (Warfel
and Merkel 2013; Warfel et al. 2014). More recent studies in the
baboon model have evaluated the prophylactic efficacy of human-
ized pertussis-neutralizing antibody cocktails as an adjuvant to
traditional antibiotic treatment following B. pertussis infection
(Nguyen et al. 2015).
Future Studies
Only within the past two decades, several respiratory viruses
have emerged from animal reservoirs to infect an unprepared
human population. With the density of the human population
increasing worldwide and our almost unlimited capacity for
global travel, outbreaks will continue to take place. The capacity
for respiratory pathogens to precipitously impose catastrophic dis-
ease in the human population necessitates continued biomedical
research in the investigation of novel chemical inhibitors of micro-
bial growth, biologics to reduce life-threatening acute inflamma-
tion, and vaccines. Because the nonhuman primate lung and
immune system so closely recapitulates that of humans, we will
remain reliant on this essential laboratory animal model to assess
for pathogenesis of infectious agents and efficacy of therapeutics
in the future.
Conclusions
Despite significant progress in the development of robust non-
human primate models of respiratory disease over the past
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several decades, viable pharmaceutical candidates for perma-
nent restoration of lung function and mucosal immunity
remain elusive. The comparative aspects of nonhuman primate
lung anatomy, physiology, and immunology reinforce the
necessity for conducting pharmaceutical studies in this labora-
tory animal model, but the prolonged nature of chronic respira-
tory conditions presents a major obstacle for conducting
experimental investigations in this species in a practical man-
ner. To address these challenges, expanded use of new world
monkey species with accelerated lifespans (e.g., marmosets)
may ultimately be the key to success, with the potential for
yielding critical information on the natural progression of
obstructive airways and lung function decline in the human
population.
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